Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Artesunate-amodiaquine (ASAQ) and Artemether-lumefantrine (AL) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Center Region of Cameroon

NCT04829695 is registered in ClinicalTrials.gov with University of Yaounde 1 as lead sponsor.

NCT NCT04829695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04829695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Artesunate-amodiaquine (ASAQ) and Artemether-lumefantrine (AL) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Center Region of Cameroon
Lead sponsor
University of Yaounde 1
Phase
Phase 4
Overall status
Unknown status
Start date
April 5, 2021
Completion date
December 31, 2021
Enrollment
184 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

falciparum malaria